From the publisher of BioWorld Today and Medical Device Daily
A 90-minute Audio Conference sponsored by BioWorld Today and Medical Device Daily
Date: Wednesday, July 23, 2008; 2:00-3:30pm EST
Speaker: Gary F. Giampetruzzi
Duration: 90 Minutes
What are you doing to prevent violations of the Foreign Corrupt Practices Act (FCPA)?
2007 saw 38 FCPA enforcement actions by the DoJ and SEC—more than the prior four years combined! Among those caught in the crosshairs of a Federal FCPA investigation were Medtronic, Stryker, Biomet, Smith & Nephew, Zimmer, and Johnson & Johnson.
And according to the DoJ, 2007 was "just the tip of the iceberg," with "many more matters under investigation." Likewise, the SEC is, according to an official, engaging in "a full-court press on FCPA investigations."
Pharmaceutical and medical device companies face special challenges in complying with the FCPA. In many countries, doctors and hospital staff are on the government payroll—as such, they can be considered "foreign officials," making payments to them potentially illegal. Even making contributions to an official's favored charity can run afoul of the FCPA, as Schering Plough found out in 2004.
So how do you secure your compliance program against FCPA violations? In this 90-minute audio conference, Pfizer's Assistant General Counsel and Deputy Compliance Officer Gary Giampetruzzi will provide insider insight on what kind of compliance program the U.S. government wants to see, and how to put into place the controls needed for FCPA compliance.
Learning Points or Questions to Be Answered:
- 15 red flags to indicate non-compliance—find and fix these before the DoJ and SEC do it for you!
- Activities for which you can be held accountable, even if committed by foreign subsidiaries, suppliers, or rogue employees
- 5 guidelines for creating FCPA policies, based on recent cases
- 3 foreign official risk areas—did you realize making remuneration to these people could be a Federal crime?
- Who should write procedures, and who should implement them
- Advice and resources for training staff locally and abroad
- 9 ways to audit and assess your FCPA compliance program
- Internal investigations—when to conduct one, who should conduct it, and what to do if you find evidence of non-compliance
- Issues with conducting employee interviews and collecting electronic records
- Plus — you'll get the chance to ask the speaker your own questions prior to the audio conference as well as during the live Q&A session following the presentation!
Who should attend:
- Compliance officers
- Executive management
- General/corporate counsel
- Regulatory/legislative affairs professionals
- Risk management specialists
- Sales/marketing personnel
- Training personnel
- Outside attorneys
- Finance staff/auditors
- Consultants
- International business operations
Level: Intermediate
Click here to register.
Speaker:
Gary F. Giampetruzzi is Assistant General Counsel and Deputy Compliance Officer with the International Investigations and Programs in the Corporate Compliance Group of Pfizer Inc. A frequent speaker at industry conferences on FCPA and general compliance programs, and internal and government investigations, he has been instrumental in the development of Pfizer's more centralized compliance function, and has been involved with the development of every key aspect of the compliance program. He and his headquarters and regionally based team currently have responsibility for the implementation and maintenance of these programs and systems throughout Pfizer operations around the world, working with a network of international compliance liaisons. In addition, he focuses on internal investigations across the company's research and development, manufacturing, sales and other operations around the world, and any government proceedings associated therewith.
Before joining Pfizer, Gary completed a federal clerkship in the Southern District of New York. Thereafter, he spent approximately six years with the Litigation Department of Willkie Farr & Gallagher, where he focused primarily on complex commercial litigation, state and federal criminal matters, including criminal appeals, and corporate internal investigations.
Gary graduated cum laude from St. John's University School of Law.
|
